MXCT
MaxCyte Inc
1.20$
+2.5%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 13.4% | 11.1% | 10.7% | 10.4% | 11.0% | 11.6% | 10.6% | 10.8% | 11.5% | 11.5% | 18.4% | 18.8% | |
| 86.6% | 88.9% | 89.3% | 89.6% | 89.0% | 88.4% | 89.4% | 89.2% | 88.5% | 88.5% | 81.6% | 81.2% | |
| 34.8% | 32.4% | 38.3% | 80.7% | 67.5% | 81.4% | 67.8% | 45.5% | 44.1% | 57.7% | 57.5% | 63.1% | |
| 34.5% | 28.7% | 34.3% | 32.3% | 31.7% | 25.7% | 28.2% | 55.1% | 58.4% | 72.8% | 76.9% | 85.1% | |
| 104.4% | 97.1% | 111.5% | 156.1% | 139.5% | 145.9% | 131.7% | 142.9% | 150.3% | 205.5% | 214.2% | 218.3% | |
| -17.8% | -8.2% | -22.2% | -66.4% | -50.5% | -57.4% | -42.3% | -53.7% | -61.8% | -117.0% | -132.5% | -137.1% | |
| 7.8% | 7.6% | 5.2% | 4.5% | 3.7% | 3.2% | 3.2% | 3.1% | 0.3% | – | – | – | |
| -25.6% | -15.6% | -27.3% | -70.9% | -53.2% | -59.6% | -45.2% | -56.3% | -53.3% | -91.8% | -106.3% | -135.1% | |
| – | 7.8% | 5.3% | – | 1.0% | 3.2% | 3.2% | 3.1% | -8.6% | 9.7% | – | – | |
| -25.6% | -15.6% | -27.3% | -70.9% | -53.2% | -59.6% | -45.2% | -56.3% | -53.3% | -91.8% | -106.3% | -135.1% | |
| -16.5% | -7.0% | -21.2% | -65.4% | -47.5% | -53.7% | -38.0% | -49.0% | -46.9% | -81.7% | -93.9% | -119.6% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.